Skip to main content
NewslettersWatchlist

Aequus Pharmaceuticals Inc(AQSZF)
OTC US

Today's Change
Delayed Last Update
Day Low0.0177
Day High0.0177
Open:0.0177
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Aequus Reports Second Quarter 2023 Financial Highlights and General Update
GlobeNewswire
Aequus Announces Zimed PF Now Available in Canada
GlobeNewswire
Aequus Announces Zimed PF Website Launch
GlobeNewswire
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada
GlobeNewswire
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)
Globe Newswire
Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc.
Globe Newswire
Aequus Resumes Trading on TSX Venture Exchange
Globe Newswire
Aequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products
Globe Newswire
Aequus Provides General Update and Reports Record 2021 Financial Results
Globe Newswire
Aequus Provides Update on Delay in Filing Annual Financial Statements
Globe Newswire
Aequus Provides Update on Delay in Filing Annual Financial Statements
Globe Newswire
Aequus Provides Update on Delay in Filing Annual Financial Statements
Globe Newswire
Aequus Announces Delay in Filing Annual Financial Statements
Globe Newswire
Aequus Announces Short Term Loan
Globe Newswire
Aequus Announces Director Resignation
Globe Newswire
Aequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma Medication
AccessWire
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
Globe Newswire
Aequus Reports Third Quarter 2021 Financial Highlights
Globe NewsWire
Aequus Reports Second Quarter 2021 Financial Highlights
Globe NewsWire
Aequus Strengthens Clinical Experience in Stargardt Disease with Pediatric Ophthalmology Expertise
Globe NewsWire
Aequus and reVision to Collaborate on Stargardt Disease Program
Globe NewsWire
Proactive news headlines including Marble Financial, Vuzix Corp, Talon Metals and Unigold
Globe NewsWire
Aequus Provides Commercial Update
Globe NewsWire
Aequus Provides General Update and First Quarter 2021 Financial Highlights
Globe NewsWire
Proactive North America headlines including Tetra Bio-Pharma, Naturally Splendid Entrerprises, Energy Fuels, FansUnite Entertainment and CytoDyn
Globe NewsWire
Aequus Provides General Update and Reports Record 2020 Financial Results
Globe NewsWire
Aequus to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference
Globe NewsWire
Proactive news headlines including Aequus Pharmaceuticals, Aurelius Minerals, Orogen Royalties and Mountain Valley MD Holdings
Globe NewsWire
Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada
Globe NewsWire
Proactive news headlines including Alpine 4 Technologies, Aequus Pharmaceuticals, Aurania Resources and VolitionRx
Globe NewsWire
Aequus Pharma 2021 Outlook and Holiday Wishes
Globe NewsWire
Aequus Provides Third Quarter 2020 Financial Highlights

Profile

N/A

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.